Concepedia

R. Xu

RX

Statistics

Publications

1

Citations

192

H-Index

1

Active since

2022

Affiliations

Universitat de Barcelona(Current)

R. Xu is an author at Universitat de Barcelona specializing in hepatology, radiation oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2022–2022

1

Publications

1

LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)

R.S. Finn, Masatoshi Kudo, Philippe Merle et al. · Annals of Oncology · 2022 · 192 citations

, , +9

1–1 of 1